Vinge has represented Inflexion in connection with the acquisition of the Mecenat group from IK. The acquisition of Mecenat is the first investment made through Inflexion's new Enterprise Fund VI, and Inflexion's first acquisition in Sweden.

Mecenat is a digital marketplace that connects students, alumni, young professionals, and seniors with well-known brands by offering access to exclusive deals, career services, and relevant events. The Mecenat group operates in both Sweden and Finland, has approximately three million members, and collaborates with more than 700 local and global brands. Mecenat's platform spans various industries, including technology, fashion, travel and entertainment.

Vinge's team mainly consisted of Christina Kokko, Maria Dahlin Kolvik, Eléonore Friberg, Carl Fredrik Wachtmeister, Madelene Andersson, and Chris Bastholm (M&A), Victor Ericsson (Tax), Helena Göransson, Karl-Gustaw Tobola, August Ahlin, and Matilda Hamner (Banking and Finance), Ian Jonsson and Siri Blomberg (IP), Simon Söderholm and Linn Aho (Employment), Carla Håkansson and Hanna Kövamees (Commercial Agreements), Katja Häglund (GDPR), Hayaat Ibrahim (Compliance), Nils Unckel and Anton Sjökvist (AIFMD), Lovisa Lewin and Alva Chambert (Competition Law and FDI), and Caroline Löv (Transaction Support Coordinator).

For more information, please see the client's press release here

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025